Attention! The information is for reference purposes!
Before taking you should consult with a doctor!
SITE GUIDE ONLY. Not a pharmacy! We do not sell drugs! Nothing!

Description medications: Emoksipin (Emoxipinum)

Emoksipin (Emoxipinum). 3-Hydroxy-6-methyl-2-ethyl-pyridine (or 6-methyl-2-ethyl-pyridin-3-ol) hydrochloride.

White (with kremovatym) crystalline powder. Easily soluble in water.

Emoksipin is an antioxidant, have anti, angioprotektornoy, antiplatelet activity.

Initially, the drug has been proposed for use in ophthalmic practice as a means for the treatment of intraocular hemorrhage, diabetic retinopathy, central chorioretinal dystrophy, thrombosis of the central retinal vein and its branches, post-traumatic hemorrhage, complicated myopia. The drug is prescribed as to protect the retina of the eye when exposed to high intensity light (laser and sunburn, laser photocoagulation). In addition, emoksipin used in the postoperative period in patients with glaucoma, choroidal detachment (choroidal).

Recently emoksipin successfully used in the treatment of other diseases associated with increased lipid peroxidation and hypoxia (myocardial infarction, acute blood loss, skin diseases, glaucoma and others.).

With eye diseases emoksipin used retrobulbarno, parabulbarno and subkonyunktivalno. Retrobulbarno drug is administered in a dose of 0.5 ml of 1 1% solution once daily for 10 - 15 days; subconjunctivally and parabulbarly - 0.2 - 0.5 mL of 1% solution of 1 times a day every day or every other day for 10 - 30 days. If necessary, treatment can be repeated 2 - 3 times a year. To protect the retina with laser photocoagulation, retrobulbar emoksipin administered in a dose of 0.5 ml of a 1% solution of the day and for 1 hour immediately before coagulation. Next the preparation is applied for 2 - 10 days, once a day 1 retrobulbarno the same dose (0.5 ml of 1% solution). In coagulation tumors emoksipin before delimiting and destructive coagulation in the above scheme. emoxipin Treatment should be under the control of blood clotting.

Emoksipin in ophthalmic practice is also used for a 1% solution droplets.

Patients with acute myocardial infarction emoksipin administered intravenously at 10 mg / kg daily for 5 days followed by intramuscular injection of 1 mg / kg for 15 days. It noted the acceleration of reparative processes and reducing areas of necrosis.

If true eczema emoksipin injected intramuscularly 1 ml of a 1% solution of 2 times a day for 14 days.

The drug is generally well tolerated. With retro and parabulbarnom a possible sensation of pain, burning, itching, redness, and seal paraorbital tissue absorbable yourself. To remove allergic phenomena recommended instillation of corticosteroids.

emoxipine solutions should not be mixed with solutions of other drugs.

Product: 1% solution in ampoules of 1 ml; 1% solution in vials (eye drops; Solutio Emoxypini 1% Guttae ophthalmisae.) In 5 ml.

Storage: List B.